Abstract | BACKGROUND: Intestinal ischemia reperfusion (IR) is associated with morbidity and mortality. We first examined the role of levosimendan in the protection of intestine after mesenteric IR. METHODS: The rats were divided into six groups: (1) Control group; (2) Levosimendan group; (3) Ischemia group (60 min of occlusion); (4) IR group (60 min of occlusion and then 60 min reperfusion); (5) IR + 1 mg/kg levosimendan group: Levosimendan was given intraperitonally 30 min prior to the ischemia; (6) IR + 2 mg/kg levosimendan group. RESULTS: The levels of TNF-α, IL-6, and IL-1β were found to have increased in the IR group. The serum levels of TNF-α, IL-6, and IL-1β were found to have decreased as a result of the administration of both doses of levosimendan in the IR. Relative TNF-α and NFκB mRNA levels was decreased by administration of both doses of levosimendan in the IR. SOD activity and GSH levels for IR group were lower than, and 8-ISO levels were higher than, those of the sham-operated rat and ischemia alone group. CONCLUSIONS:
|
Authors | Beyzagul Polat, Abdulmecit Albayrak, Zekai Halici, Emre Karakus, Yasin Bayir, Elif Demirci, Elif Cadirci, Ersan Odaci, Muhammed Yayla, Sabri Selcuk Atamanalp |
Journal | Journal of investigative surgery : the official journal of the Academy of Surgical Research
(J Invest Surg)
Vol. 26
Issue 6
Pg. 325-33
(Dec 2013)
ISSN: 1521-0553 [Electronic] United States |
PMID | 23957729
(Publication Type: Journal Article)
|
Chemical References |
- Hydrazones
- Interleukin-1beta
- Interleukin-6
- NF-kappa B
- Pyridazines
- RNA, Messenger
- Tumor Necrosis Factor-alpha
- Simendan
|
Topics |
- Animals
- Hydrazones
(therapeutic use)
- Interleukin-1beta
(blood)
- Interleukin-6
(blood)
- Intestines
(blood supply, pathology)
- NF-kappa B
(genetics)
- Pyridazines
(therapeutic use)
- RNA, Messenger
(metabolism)
- Rats
- Reperfusion Injury
(pathology, prevention & control)
- Simendan
- Tumor Necrosis Factor-alpha
(blood)
|